Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Cell Stem Cell
|
June 3, 2017
The Dynamic Identity of Intestinal Cancer Stem Cells
Piero Dalerba
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 1, 2022
Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer
Piero Dalerba
Lancet (London, England)
|
August 9, 2011
Blood-cell banking for workers at the Fukushima Daiichi nuclear power plant
Piero Dalerba
Cell Stem Cell
|
July 6, 2013
Oncogenic miRNAs and the perils of losing control of a stem cell's epigenetic identity
Piero Dalerba, Michael F Clarke
Cell Stem Cell
|
March 29, 2008
Cancer stem cells and tumor metastasis: first steps into uncharted territory
Piero Dalerba, Michael F Clarke
Bioinformatics (Oxford, England)
|
August 31, 2018
A cluster robustness score for identifying cell subpopulations in single cell gene expression datasets from heterogeneous tissues and tumors
Itamar Kanter, Piero Dalerba, Tomer Kalisky
The New England Journal of Medicine
|
May 6, 2020
A Trial of Lopinavir-Ritonavir in Covid-19
Piero Dalerba, Bruce Levin, John L Thompson
The New England Journal of Medicine
|
June 2, 2016
CDX2 as a Prognostic Biomarker in Colon Cancer
Piero Dalerba, Debashis Sahoo, Michael F Clarke
Annual Review of Medicine
|
September 28, 2006
Cancer stem cells: models and concepts
Piero Dalerba, Robert W Cho, Michael F Clarke
Journal of Global Health
|
October 11, 2024
Global obesity epidemic and rising incidence of early-onset cancers
Jianjiu Chen, Piero Dalerba, Mary Beth Terry, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Cell Stem Cell
|
June 3, 2017
The Dynamic Identity of Intestinal Cancer Stem Cells
Piero Dalerba
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 1, 2022
Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer
Piero Dalerba
Lancet (London, England)
|
August 9, 2011
Blood-cell banking for workers at the Fukushima Daiichi nuclear power plant
Piero Dalerba
Cell Stem Cell
|
July 6, 2013
Oncogenic miRNAs and the perils of losing control of a stem cell's epigenetic identity
Piero Dalerba, Michael F Clarke
Cell Stem Cell
|
March 29, 2008
Cancer stem cells and tumor metastasis: first steps into uncharted territory
Piero Dalerba, Michael F Clarke
Bioinformatics (Oxford, England)
|
August 31, 2018
A cluster robustness score for identifying cell subpopulations in single cell gene expression datasets from heterogeneous tissues and tumors
Itamar Kanter, Piero Dalerba, Tomer Kalisky
The New England Journal of Medicine
|
May 6, 2020
A Trial of Lopinavir-Ritonavir in Covid-19
Piero Dalerba, Bruce Levin, John L Thompson
The New England Journal of Medicine
|
June 2, 2016
CDX2 as a Prognostic Biomarker in Colon Cancer
Piero Dalerba, Debashis Sahoo, Michael F Clarke
Annual Review of Medicine
|
September 28, 2006
Cancer stem cells: models and concepts
Piero Dalerba, Robert W Cho, Michael F Clarke
Journal of Global Health
|
October 11, 2024
Global obesity epidemic and rising incidence of early-onset cancers
Jianjiu Chen, Piero Dalerba, Mary Beth Terry, et al.
Page
of 5